Vidipha Central Pharmaceutical JSC

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 68.01% vs -0.21% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -22.96% vs 34.67% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "358,641.50",
          "val2": "213,464.80",
          "chgp": "68.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "19,589.40",
          "val2": "23,591.40",
          "chgp": "-16.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3,135.10",
          "val2": "4,052.40",
          "chgp": "-22.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "11,991.50",
          "val2": "15,565.60",
          "chgp": "-22.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "38.80%",
          "val2": "84.10%",
          "chgp": "-4.53%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -8.32% vs 1.14% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -10.47% vs 18.55% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "934,486.80",
          "val2": "1,019,316.70",
          "chgp": "-8.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "112,234.30",
          "val2": "126,749.30",
          "chgp": "-11.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "14,848.80",
          "val2": "27,558.60",
          "chgp": "-46.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "71,823.20",
          "val2": "80,218.80",
          "chgp": "-10.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "87.60%",
          "val2": "97.30%",
          "chgp": "-0.97%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

358,641.50

213,464.80

68.01%

Operating Profit (PBDIT) excl Other Income

19,589.40

23,591.40

-16.96%

Interest

3,135.10

4,052.40

-22.64%

Exceptional Items

0.00

0.00

Consolidate Net Profit

11,991.50

15,565.60

-22.96%

Operating Profit Margin (Excl OI)

38.80%

84.10%

-4.53%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 68.01% vs -0.21% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is -22.96% vs 34.67% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

934,486.80

1,019,316.70

-8.32%

Operating Profit (PBDIT) excl Other Income

112,234.30

126,749.30

-11.45%

Interest

14,848.80

27,558.60

-46.12%

Exceptional Items

0.00

0.00

Consolidate Net Profit

71,823.20

80,218.80

-10.47%

Operating Profit Margin (Excl OI)

87.60%

97.30%

-0.97%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -8.32% vs 1.14% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -10.47% vs 18.55% in Dec 2023

All Annual Results